EN
中文
EN
Who We Are
Newsroom
Innovation
Products
Investor Relations
Careers
Contact Us
Information Disclosure
Home
>
Investor Relations
>
Information Disclosure
H Share
RESUMPTION OF TRADING
INSIDE INFORMATION RECOMBINANT COVID-19 VACCINE (ADENOVIRUS TYPE 5 VECTOR) APPROVED FOR EMERGENCY USE IN MEXICO
TRADING HALT
Monthly Return of Equity Issuer on Movements in Securities
INSIDE INFORMATION PROGRESS ON PHASE III CLINICAL TRIAL OF RECOMBINANT COVID-19 VACCINE (ADENOVIRUS TYPE 5 VECTOR)
INSIDE INFORMATION RESULTS FORECAST FOR THE YEAR 2020
Monthly Return of Equity Issuer on Movements in Securities
Monthly Return of Equity Issuer on Movements in Securities
Monthly Return of Equity Issuer on Movements in Securities
THIRD QUARTERLY REPORT FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2020
1
37
38
39
40
41
52
津公网安备12011602300399
